£69.58

Drug Resistant Neoplasms (Cancer Etiology Diagnosis and Treatment Series)

Price data last checked 94 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£70 today · usual range £0–£0 · best ever £39

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 637 days • 637 data points (No recent data available)

Historical
Generating forecast...
£94.69 £33.18 £46.60 £60.02 £73.44 £86.86 £100.28 09 June 2024 15 November 2024 23 April 2025 29 September 2025 07 March 2026

Price Distribution

Price distribution over 637 days • 5 price ranges

Days at Price
Current Price
10 days 30 days 320 days · current 155 days 122 days 0 80 160 240 320 £39-50 £50-61 £61-72 £72-84 £84-95 Days at Price

Price Analysis

Most common range: £61-72 (320 days, 50.2%)

Price range: £39 - £95

Price levels: 5 price ranges over 637 days

Description

One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells. The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100% effective against disseminated cancer. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somatic cell genetic differences in tumours, even those from the same tissue of origin. Frequently, resistance is intrinsic to the cancer, but as therapy becomes more and more effective, acquired resistance has also become common. The most common reason for acquisition of resistance to a broad range of anticancer drugs is expression of one or more energy-dependent transporters that detect and eject anticancer drugs from cells. Studies on the mechanisms of cancer drug resistance have yielded important information about how to circumvent this resistance to improve cancer chemotherapy and its implications for pharmacokinetics of many commonly used drugs. This book presents new and important research in this field.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
29 March 2010
Listed Since
06 June 2009

Barcode

No barcode data available

Similar Products You Might Like

Progress in Cancer Drug Resistance Research
98% match

Progress in Cancer Drug Resistance Research

£97.27 09 Mar 2026
Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)
97% match

Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)

Academic Press

£113.12 13 Jan 2026
Drug Resistance in Cancer: Mechanisms and Models
97% match

Drug Resistance in Cancer: Mechanisms and Models

Cambridge University Press

£127.00 08 Jan 2026
Cancer Drug Resistance (Cancer Drug Discovery and Development)
97% match

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Humana

£35.15 13 Jan 2026
Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)
97% match

Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Springer

£149.64 14 Apr 2026
Cancer Drug Resistance (Cancer Drug Discovery and Development)
97% match

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Humana

£154.49 13 Jan 2026
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
96% match

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Humana

£87.47 24 Feb 2026
Cancer Cell Chemoresistance And Chemosensitization
96% match

Cancer Cell Chemoresistance And Chemosensitization

Scientific Publishing

£148.00 11 Mar 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
96% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£82.73 09 Mar 2026
Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches: v. 1
96% match

Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches: v. 1

Springer

£184.00 12 Jan 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
96% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£148.69 13 Jan 2026
Drug Repurposing in Cancer Therapy: Approaches and Applications
96% match

Drug Repurposing in Cancer Therapy: Approaches and Applications

Academic Press

£132.99 12 Jan 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
96% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£165.95 09 Apr 2026
Wiley Anticancer Therapeutics - Oncology Drug Design Book
96% match

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Wiley

£133.27 15 Apr 2026
Springer - Molecular Mechanisms of Tumor Cell Resistance
96% match

Springer - Molecular Mechanisms of Tumor Cell Resistance

Springer

£93.87 19 Apr 2026
Drug Resistance in Cancer Cells
96% match

Drug Resistance in Cancer Cells

Springer

£107.73 08 Apr 2026
New Trends in the Molecular and Biological Basis for Clinical Oncology
96% match

New Trends in the Molecular and Biological Basis for Clinical Oncology

Springer

£77.87 28 Feb 2026
Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)
95% match

Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

Springer

£174.62 22 Jan 2026
Springer - Drug Resistance in Leukemia and Lymphoma III
95% match

Springer - Drug Resistance in Leukemia and Lymphoma III

Springer

£150.48 06 Mar 2026
Drug Resistance: 87 (Cancer Treatment and Research, 87)
95% match

Drug Resistance: 87 (Cancer Treatment and Research, 87)

Springer

£211.51 13 Jan 2026
Drug Resistance: 87 (Cancer Treatment and Research, 87)
95% match

Drug Resistance: 87 (Cancer Treatment and Research, 87)

Springer

£243.42 13 Jan 2026
CRC Press - Chemistry and Pharmacology of Anticancer Drugs
95% match

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£133.99 15 Apr 2026
Chemistry and Pharmacology of Anticancer Drugs
95% match

Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£192.76 17 Apr 2026
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)
95% match

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Humana

£149.75 13 Jan 2026